Met Life Investment Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 30,822 shares of SUPN stock, worth $988,153. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,822
Previous 29,428 4.74%
Holding current value
$988,153
Previous $917,000 21.48%
% of portfolio
0.01%
Previous 0.01%

Shares

42 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$31.89 - $37.83 $44,454 - $52,735
1,394 Added 4.74%
30,822 $1.11 Million
Q2 2024

Aug 13, 2024
BUY
$25.99 - $33.85 $88,963 - $115,868
3,423 Added 13.16%
29,428 $787,000
Q1 2024

May 14, 2024
BUY
$27.11 - $35.17 $704,995 - $914,595
26,005 New
26,005 $887,000
Q2 2023

Apr 29, 2024
BUY
$29.91 - $38.73 $777,809 - $1.01 Million
26,005 New
26,005 $781,000
Q1 2023

May 09, 2024
BUY
$34.93 - $42.03 $908,354 - $1.09 Million
26,005 New
26,005 $942 Million
Q4 2022

May 10, 2024
SELL
$31.09 - $37.88 $25,929 - $31,591
-834 Reduced 3.11%
26,005 $927,000
Q4 2022

Mar 22, 2023
SELL
$31.09 - $37.88 $25,929 - $31,591
-834 Reduced 3.11%
26,005 $927,000
Q4 2022

Feb 15, 2023
SELL
$31.09 - $37.88 $25,929 - $31,591
-834 Reduced 3.11%
26,005 $927,000
Q3 2022

May 10, 2024
SELL
$28.79 - $35.41 $29,653 - $36,472
-1,030 Reduced 3.7%
26,839 $908,000
Q3 2022

Jun 14, 2023
BUY
$28.79 - $35.41 $24,010 - $29,531
834 Added 3.21%
26,839 $908,000
Q3 2022

Mar 22, 2023
SELL
$28.79 - $35.41 $29,653 - $36,472
-1,030 Reduced 3.7%
26,839 $908,000
Q3 2022

Nov 14, 2022
SELL
$28.79 - $35.41 $29,653 - $36,472
-1,030 Reduced 3.7%
26,839 $909,000
Q2 2022

Jun 20, 2023
BUY
$25.33 - $34.25 $47,215 - $63,842
1,864 Added 7.17%
27,869 $805,000
Q1 2022

May 10, 2024
BUY
$28.51 - $32.9 $794,545 - $916,890
27,869 New
27,869 $900,000
Q1 2022

Jun 20, 2023
BUY
$28.51 - $32.9 $53,142 - $61,325
1,864 Added 7.17%
27,869 $900,000
Q1 2022

Mar 22, 2023
BUY
$28.51 - $32.9 $281,450 - $324,788
9,872 Added 54.85%
27,869 $900,000
Q1 2022

May 12, 2022
BUY
$28.51 - $32.9 $281,450 - $324,788
9,872 Added 54.85%
27,869 $901,000
Q4 2021

Jun 21, 2023
SELL
$26.37 - $34.22 $211,170 - $274,033
-8,008 Reduced 30.79%
17,997 $524,000
Q3 2021

Jun 21, 2023
SELL
$23.54 - $31.39 $188,508 - $251,371
-8,008 Reduced 30.79%
17,997 $479,000
Q2 2021

May 17, 2024
SELL
$26.72 - $33.19 $120,159 - $149,255
-4,497 Reduced 19.99%
17,997 $554,000
Q2 2021

Jun 21, 2023
SELL
$26.72 - $33.19 $213,973 - $265,785
-8,008 Reduced 30.79%
17,997 $554,000
Q2 2021

Mar 22, 2023
SELL
$26.72 - $33.19 $120,159 - $149,255
-4,497 Reduced 19.99%
17,997 $554,000
Q2 2021

Aug 16, 2021
SELL
$26.72 - $33.19 $120,159 - $149,255
-4,497 Reduced 19.99%
17,997 $554,000
Q1 2021

May 17, 2024
SELL
$24.15 - $31.45 $84,790 - $110,420
-3,511 Reduced 13.5%
22,494 $588,000
Q1 2021

Jun 26, 2023
SELL
$24.15 - $31.45 $84,790 - $110,420
-3,511 Reduced 13.5%
22,494 $589 Million
Q4 2020

Jun 22, 2023
SELL
$17.7 - $25.81 $62,144 - $90,618
-3,511 Reduced 13.5%
22,494 $565,000
Q3 2020

Jun 26, 2023
SELL
$20.2 - $25.05 $70,922 - $87,950
-3,511 Reduced 13.5%
22,494 $468,000
Q2 2020

May 24, 2024
SELL
$17.09 - $24.89 $60,002 - $87,388
-3,511 Reduced 13.5%
22,494 $534 Million
Q2 2020

Jun 26, 2023
SELL
$17.09 - $24.89 $60,002 - $87,388
-3,511 Reduced 13.5%
22,494 $534,000
Q1 2020

Jul 12, 2023
SELL
$14.45 - $24.69 $50,733 - $86,686
-3,511 Reduced 13.5%
22,494 $404,000
Q4 2019

Jul 12, 2023
SELL
$19.93 - $29.13 $69,974 - $102,275
-3,511 Reduced 13.5%
22,494 $533,000
Q3 2019

Jul 12, 2023
SELL
$25.47 - $33.37 $89,425 - $117,162
-3,511 Reduced 13.5%
22,494 $618,000
Q2 2019

Jul 12, 2023
SELL
$29.96 - $38.87 $105,189 - $136,472
-3,511 Reduced 13.5%
22,494 $744,000
Q1 2019

Jul 13, 2023
SELL
$32.77 - $41.99 $115,055 - $147,426
-3,511 Reduced 13.5%
22,494 $788,000
Q4 2018

Jul 13, 2023
SELL
$30.84 - $49.51 $108,279 - $173,829
-3,511 Reduced 13.5%
22,494 $747,000
Q4 2018

Mar 22, 2023
SELL
$30.84 - $49.51 $383,187 - $615,161
-12,425 Reduced 35.58%
22,494 $747,000
Q4 2018

Feb 14, 2019
SELL
$30.84 - $49.51 $383,187 - $615,161
-12,425 Reduced 35.58%
22,494 $747,000
Q3 2018

Jul 13, 2023
SELL
$42.7 - $56.55 $149,919 - $198,547
-3,511 Reduced 13.5%
22,494 $1.13 Million
Q3 2018

Mar 22, 2023
BUY
$42.7 - $56.55 $380,627 - $504,086
8,914 Added 34.28%
34,919 $1.76 Million
Q3 2018

Nov 14, 2018
BUY
$42.7 - $56.55 $530,547 - $702,633
12,425 Added 55.24%
34,919 $1.76 Million
Q2 2018

Aug 15, 2018
BUY
$44.1 - $59.85 $45,070 - $61,166
1,022 Added 4.76%
22,494 $1.35 Million
Q4 2017

Feb 15, 2018
BUY
$36.4 - $42.6 $781,580 - $914,707
21,472
21,472 $856,000

Others Institutions Holding SUPN

# of Institutions
303
Shares Held
60.6M
Call Options Held
22.3K
Put Options Held
6K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.72B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email